| Effects of expectation on placebo-induced dopamine release in Parkinson disease SC Lidstone, M Schulzer, K Dinelle, E Mak, V Sossi, TJ Ruth, ... Archives of general psychiatry 67 (8), 857-865, 2010 | 359 | 2010 |
| Accurate event-driven motion compensation in high-resolution PET incorporating scattered and random events A Rahmim, K Dinelle, JC Cheng, MA Shilov, WP Segars, SC Lidstone, ... IEEE transactions on medical imaging 27 (8), 1018-1033, 2008 | 158 | 2008 |
| Outcome measurement in functional neurological disorder: a systematic review and recommendations S Pick, DG Anderson, AA Asadi-Pooya, S Aybek, G Baslet, BR Bloem, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (6), 638-649, 2020 | 150 | 2020 |
| Neuroimaging in functional neurological disorder: state of the field and research agenda DL Perez, TR Nicholson, AA Asadi-Pooya, I Bègue, M Butler, AJ Carson, ... NeuroImage: Clinical 30, 102623, 2021 | 144 | 2021 |
| Understanding the placebo effect: contributions from neuroimaging SCC Lidstone, AJ Stoessl Molecular Imaging and Biology 9, 176-185, 2007 | 114 | 2007 |
| Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases SC Lidstone, M Costa-Parke, EJ Robinson, T Ercoli, J Stone Journal of Neurology, Neurosurgery & Psychiatry 93 (6), 609-616, 2022 | 84 | 2022 |
| Placebo effect and dopamine release R de la Fuente-Fernández, S Lidstone, AJ Stoessl Parkinson’s Disease and Related Disorders, 415-418, 2006 | 75 | 2006 |
| Psychosocial issues in young-onset Parkinson's disease: current research and challenges SM Calne, SC Lidstone, A Kumar Parkinsonism & related disorders 14 (2), 143-150, 2008 | 69 | 2008 |
| Opinions and clinical practices related to diagnosing and managing functional (psychogenic) movement disorders: changes in the last decade K LaFaver, AE Lang, J Stone, F Morgante, M Edwards, S Lidstone, ... European Journal of Neurology 27 (6), 975-984, 2020 | 65 | 2020 |
| What is the role of a specialist assessment clinic for FND? Lessons from three national referral centers S Aybek, SC Lidstone, G Nielsen, L MacGillivray, CL Bassetti, AE Lang, ... The Journal of neuropsychiatry and clinical neurosciences 32 (1), 79-84, 2020 | 60 | 2020 |
| Great expectations: the placebo effect in Parkinson’s disease SC Lidstone Placebo, 139-147, 2014 | 55 | 2014 |
| The placebo response as a reward mechanism SC Lidstone, R de la Fuente-Fernandez, AJ Stoessl Seminars in pain medicine 3 (1), 37-42, 2005 | 49 | 2005 |
| The evidence for multidisciplinary care in Parkinson’s disease SC Lidstone, M Bayley, AE Lang Expert Review of Neurotherapeutics 20 (6), 539-549, 2020 | 41 | 2020 |
| Integrated therapy for functional movement disorders: time for a change SC Lidstone, L MacGillivray, AE Lang Movement disorders clinical practice 7 (2), 169, 2020 | 40 | 2020 |
| Functional neurological disorder is a feminist issue C McLoughlin, I Hoeritzauer, V Cabreira, S Aybek, C Adams, J Alty, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (10), 855-862, 2023 | 35 | 2023 |
| Investigation of subject motion encountered during a typical positron emission tomography scan K Dinelle, S Blinder, JC Cheng, S Lidstone, K Buckley, TJ Ruth, V Sossi 2006 IEEE Nuclear Science Symposium Conference Record 6, 3283-3287, 2006 | 27 | 2006 |
| Ten myths about functional neurological disorder SC Lidstone, R Araújo, J Stone, BR Bloem | 24 | 2020 |
| Diagnosing functional neurological disorder: seeing the whole picture SC Lidstone, W Nassif, J Juncos, SA Factor, AE Lang CNS spectrums 26 (6), 593-600, 2021 | 20 | 2021 |
| Variations in hospitalization rates across Parkinson's foundation centers of excellence F Zeldenrust, S Lidstone, S Wu, MS Okun, F Cubillos, J Beck, T Davis, ... Parkinsonism & Related Disorders 81, 123-128, 2020 | 13 | 2020 |
| Neuropsychiatric phenotypes in functional movement disorder GS Gilmour, LK Langer, AE Lang, L MacGillivray, SC Lidstone CNS spectrums 28 (6), 747-755, 2023 | 8 | 2023 |
